Abstract:
ADMINISTRATION OF AN EFFECTIVE AMOUNT OF 1-(2-PYRIDYL) PIPERAZINE OR A NONTOXIC ACID ADDITION SALT THEREOF CONTROLS TREMOR SYMPTOMATIC OR PARKINSONISM IN MAMMALS. DAILY DOES RANGING FROM 10 MG./KG. TO 90 MG./KG. ARE CONSIDERED EFFECTIVE.
Abstract:
THE TREMOR OF PARKINSONS''S SYNDROME IN MAMMALS IS SUPPRESSED BY THE ADMINSTRATION OF A COMPIUND OF THE FORMULA:
2-(4-R-PIPERAZIN-1-YL)-QUINOLINE
IN WHICH R IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF H AND CH3, AND NONTOXIC PHARMACOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF. THESE COMPOUNDS MAY BE UTILIZED IN CONJUNCTION WITH PHARMACEUTICALLY ACCEPTABLE VEHICLES THEREFOR.
Abstract:
A COMPOSITION COMPRISING 1-(2-PYRIDYL)PIPERAZINE AND LEVODOPA IN A RESPECTIVE WEIGHT RATIO OF FROM 1:320 TO 1:20 CONTROLS TREMO SYMPTOMATIC OF PARKINSONISM IN MAMMALS. PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 1-(2-PYRIDYL) PIPERAZINE CAN BE SUBSTITUTED IN LIEU OF THE PARENT COMPOUND IN THE COMPOSITION.
Abstract:
ADMINISTRATION OF 1-(2-PYRIDYL)PIPERAZINE OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF IS DISCLOSED AS A CHEMOTHERAPEUTIC METHOD OF TREATING MANIFESTATIONS OF DEPRESSION IN EXPERIMENTAL MAMMALS. DAILY DOSES RANGING FROM 2 MG./KG. TO 60 MG./KG. PER DAY ARE CONSIDERED EFFECTIVE.